This powerful economic indicator is sending a clear message about stocks for 2026
When consumers are in a buying mood, their shopping list includes the stock market. View Source Mark Hulbert MarketWatch.com – Top Stories February 3, 2026…
Category: MarketWatch
Trump and Warsh aren’t holding a joint press conference. It could signal a new era of less Fed talk.
Economists have expressed surprise and disappointment about the absence of any public remarks, which had been a routine part of the Fed nomination process going…
Wall Street’s ‘smart money’ bought gold and silver just before they crashed. Learn from their predictable mistakes.
It should surprise absolutely nobody that global fund managers were heavily overinvested in commodities just before commodity prices collapsed at the end of last week.…
Alphabet’s stock is the hottest in Big Tech, raising the bar for earnings
Alphabet’s stock has rallied 80% in the last six months on AI enthusiasm. Here’s how the Google parent can keep the momentum going. View Source…
Disney’s new CEO Josh D’Amaro faces a tough road ahead. Here’s what to expect.
Josh D’Amaro will become the ninth person to serve as Disney’s CEO in its 102-year history. View Source Lukas I. Alpert MarketWatch.com – Top Stories…
Walmart just became a $1 trillion company. Here’s what it needs to do to remain one.
Walmart’s journey to a $1 trillion market cap came after embracing technology and providing its customers with greater relief from inflation. View Source Bill Peters…
Is a Tesla-SpaceX deal on the table?
Experts are split on the merits of a Tesla-SpaceX combination, which could further Elon Musk’s dream of corporate “convergence,” but potentially at a cost to…
Nvidia’s stock needs a spark. Here’s how it can get one.
After a stretch of underperformance, Nvidia’s stock could come alive after earnings, upcoming industry events and the expected launch of new AI models by companies…
60% of buyers paid below asking price in 2025. Here’s where they found the best deals.
A quarter of recent home buyers who paid below the list price got a discount of 10% or more, the highest share since 2012 View…
Pfizer’s stock falls after mixed response to weight-loss data for drug set to compete with Lilly’s Zepbound
Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the Trump administration’s policies on…